Accusing Walmart Inc. of exacerbating the U.S. opioid epidemic by “systematically violating” the Controlled Substances Act (CSA) through its pharmacies’ dispensing practices and through the company’s distribution of the products to its pharmacies, the Department of Justice (DOJ) has ridiculed Walmart’s understanding of its obligations under the statute (United States v. Walmart Inc.... Read More